co.don AG is one of the leading specialists worldwide in cell cultivation for the regenerative treatment of articular cartilage defects and spinal disc defects.
In many cases the use of the company's patented pharmaceutical product can avert or delay the need for joint and spinal disc replacement surgery. Orthopaedic, accident and neuro-surgeons are increasingly applying these regenerative therapy methods.
Market capitalization (28-Jun-2017)
Closing share price (28-Jun-2017)